Article Contents ::
- 1 The Brand Name OKAVAX Has Generic Salt :: Varicella
- 2 OKAVAX Is From Company Aventis Pas. Priced :: Rs. 1468
- 3 OKAVAX have Varicella is comes under Sub class #N/A of Main Class #N/A
- 4 Main Medicine Class:: #N/A Sub Medicine Class :: #N/A
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
The Brand Name OKAVAX Has Generic Salt :: Varicella
OKAVAX Is From Company Aventis Pas. Priced :: Rs. 1468
OKAVAX have Varicella is comes under Sub class #N/A of Main Class #N/A
Main Medicine Class:: #N/A Sub Medicine Class :: #N/A
|Salt Name : OR Generic Name||Form||Price : MRP /Probable||Packing|
|Varicella||VAC||Rs. 1468||1 V+1 D|
Indications for Drugs ::
Drug Dose ::
Adults Indicated for all adults without evidence of immunity to varicella. 2 dose series: 0.5 mL SC, repeat at least 4 weeks later. Routine vaccination 2 dose series: 0.5 mL SC 1st dose: 12-15 months 2nd dose: 4-6 years; may be administered before age 4 yr, provided at least 3 months have elapsed since the first dose
Do not administer to individuals with a history of anaphylactic or severe allergic reaction to any component of the vaccine (including neomycin and gelatin) or to a previous dose of a varicella-containing vaccine.
Drug Precautions ::
5.1 Management of Allergic Reactions Adequate treatment provisions, including epinephrine injection (1:1000), should be available for immediate use should anaphylaxis occur. 5.2 Family History of Immunodeficiency Vaccination should be deferred in patients with a family history of congenital or hereditary immunodeficiency until the patient’s immune status has been evaluated and the patient has been found to be immunocompetent. 5.3 Use in HIV-Infected Individuals The Advisory Committee for Immunization Practices (ACIP) has recommendations on the use of varicella vaccine in HIV-infected individuals. 5.4 Risk of Vaccine Virus Transmission Post-marketing experience suggests that transmission of vaccine virus may occur rarely between healthy vaccinees who develop a varicella-like rash and healthy susceptible contacts. Transmission of vaccine virus from a mother who did not develop a varicella-like rash to her newborn infant has been reported.
Drug Side Effects ::
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a vaccine cannot be directly compared to rates in the clinical trials of another vaccine and may not reflect the rates observed in clinical practice.
Pregnancy category ::
Drug Mode of Action ::
Live, attenuated varicella virus stimulates active immunity to disease caused by varicella-zoster virus. Conveys active immunity via stimulation of production of endogenously produced antibodies .
Drug Interactions ::
Concurrent use may interfere with the immune response to certain live vaccines.